Anticonvulsants

0 marketed 1 in Phase 3

This page covers all Anticonvulsants drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Voltage-dependent sodium channels.

Targets

Voltage-dependent sodium channels

Phase 3 pipeline (1)

Topiramate; Carbamazepine; Valproate · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · Neurology
Topiramate is an anticonvulsant that acts as a voltage-dependent sodium channel blocker, whereas Carbamazepine is a tricyclic compound that stabilizes inactivated sodium channels, and Valproate is a fatty acid with anticonvulsant properties.